GOP Reps. Moolenaar & Cline urge FDA's Diamantas to reject Chinese clinical trial data unless sites are audited annually, citing patient safety risks & 3 deaths.
Two Republican lawmakers are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency, and …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
U.S. House lawmakers say the FDA should not rely on Chinese clinical-trial data without recent inspections, citing opaque…
A key US House Republican urges Treasury to restrict US investment in China biotech, spotlighting Bristol Myers Squibb's Hengrui…
Bipartisan Michigan lawmakers unveil a bill subjecting US-China biotech deals to outbound investment screening, citing national…
Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill…
The U.S. House Select Committee on China has opened investigations into five pharmaceutical companies regarding their clinical…
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in…
